Andrea Huwiler
Overview
Explore the profile of Andrea Huwiler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
2120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Stepanovska Tanturovska B, Zivkovic A, Imeri F, Homann T, Kleuser B, Stark H, et al.
Molecules
. 2021 Sep;
26(17).
PMID: 34500564
Sphingosine 1-phosphate (S1P) is an extensively studied signaling molecule that contributes to cell proliferation, survival, migration and other functions through binding to specific S1P receptors. The cycle of S1P internalization...
12.
Huwiler A, Pfeilschifter J
Circ Res
. 2021 Jul;
129(2):237-239.
PMID: 34236886
No abstract available.
13.
Imeri F, Stepanovska Tanturovska B, Schwalm S, Saha S, Zeng-Brouwers J, Pavenstadt H, et al.
Matrix Biol
. 2021 May;
98:32-48.
PMID: 34015468
The sphingosine 1-phosphate (S1P) is a bioactive sphingolipid that is now appreciated as key regulatory factor for various cellular functions in the kidney, including matrix remodeling. It is generated by...
14.
Psarra A, Theodoropoulou M, Erhardt M, Mertiri M, Mantzourani C, Vasilakaki S, et al.
Biomolecules
. 2021 Mar;
11(2).
PMID: 33668480
Prostaglandin E (PGE) is a key mediator of inflammation, and consequently huge efforts have been devoted to the development of novel agents able to regulate its formation. In this work,...
15.
Imeri F, Stepanovska Tanturovska B, Zivkovic A, Enzmann G, Schwalm S, Pfeilschifter J, et al.
Neuropharmacology
. 2021 Jan;
186:108464.
PMID: 33460688
The sphingosine 1-phosphate (S1P) receptor 1 (S1P) has emerged as a therapeutic target for the treatment of multiple sclerosis (MS). Fingolimod (FTY720) is the first functional antagonist of S1P that...
16.
Schwalm S, Beyer S, Hafizi R, Trautmann S, Geisslinger G, Adams D, et al.
Cell Signal
. 2020 Dec;
79:109881.
PMID: 33301900
Renal fibrosis is characterized by chronic inflammation and excessive accumulation of extracellular matrix and progressively leads to functional insufficiency and even total loss of kidney function. In this study we...
17.
Stepanovska B, Zivkovic A, Enzmann G, Tietz S, Homann T, Kleuser B, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32899717
Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease of the central nervous system (CNS) which is associated with lower life expectancy and disability. The experimental antigen-induced encephalomyelitis (EAE) in...
18.
Dennhardt S, Finke K, Huwiler A, Coldewey S
Biochim Biophys Acta Mol Basis Dis
. 2020 Jul;
1866(10):165892.
PMID: 32631629
No abstract available.
19.
Schwalm S, Erhardt M, Romer I, Pfeilschifter J, Zangemeister-Wittke U, Huwiler A
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32092937
Ceramide kinase (CerK) is a lipid kinase that converts the proapoptotic ceramide to ceramide 1-phosphate, which has been proposed to have pro-malignant properties and regulate cell responses such as proliferation,...
20.
Stepanovska B, Lange A, Schwalm S, Pfeilschifter J, Coldewey S, Huwiler A
Int J Mol Sci
. 2020 Feb;
21(4).
PMID: 32069843
Sphingosine 1-phosphate (S1P) is a key bioactive lipid that regulates a myriad of physiological and pathophysiological processes, including endothelial barrier function, vascular tone, vascular inflammation, and angiogenesis. Various S1P receptor...